Liver Cirrhosis Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Cirrhosis, including details on alcohol, treatment, drugs, effects, causes.

Volume 4 (2007), Issue 11 (November)

1. Increase in expression of monocytic tissue factor (CD142) with monocytes and blood platelet activation in liver cirrhosis.
   Blood Coagul Fibrinolysis, 18(8): 739-44. [Abstract] [Full-text]
2. The effects of N-acetylcysteine on bile duct ligation-induced liver fibrosis in rats.
   Dig Dis Sci, 52(12): 3348-54. [Abstract] [Full-text]
3. Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells.
   Dig Dis Sci, 52(12): 3404-15. [Abstract] [Full-text]
4. Single-center experience on liver transplantation for hepatocellular carcinoma arising in alcoholic cirrhosis: results and ethical issues.
   Eur Surg Res, 40(1): 7-13. [Abstract] [Full-text]
5. Genistein modifies liver fibrosis and improves liver function by inducing uPA expression and proteolytic activity in CCl4-treated rats.
   Pharmacology, 81(1): 41-9. [Abstract] [Full-text]
6. Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus.
   Metabolism, 56(12): 1682-8. [Abstract] [Full-text]
7. Comparative protection against liver inflammation and fibrosis by a selective cyclooxygenase-2 inhibitor and a nonredox-type 5-lipoxygenase inhibitor.
   J Pharmacol Exp Ther, 323(3): 778-86. [Abstract] [Full-text]
8. Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient L-amino acid-defined diet.
   Biochem Biophys Res Commun, 364(4): 801-7. [Abstract] [Full-text]
9. Diagnostic value of hepatocellular nodule vascularity after microbubble injection for characterizing malignancy in patients with cirrhosis.
   AJR Am J Roentgenol, 189(6): 1474-83. [Abstract] [Full-text]
10. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    AJR Am J Roentgenol, 189(6): 1428-34. [Abstract] [Full-text]
11. A comparison of the frequency of antibodies to cyclic citrullinated peptides using a third generation anti-CCP assay (CCP3) in systemic sclerosis, primary biliary cirrhosis and rheumatoid arthritis.
    Clin Rheumatol, 27(1): 77-83. [Abstract] [Full-text]
12. Long-term outcome of surgical treatment for non-small cell lung cancer with comorbid liver cirrhosis.
    Ann Thorac Surg, 84(6): 1810-7. [Abstract] [Full-text]
13. Factors predicting early postoperative liver cirrhosis-related complications after lung cancer surgery in patients with liver cirrhosis.
    Interact Cardiovasc Thorac Surg, 6(6): 720-30. [Abstract] [Full-text]
14. Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices.
    Aliment Pharmacol Ther, 26(11): 1479-87. [Abstract] [Full-text]
15. Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C.
    N Engl J Med, 357(22): 2227-36. [Abstract] [Full-text]

© 2004-2008 Liver Cirrhosis Research Today. All Rights Reserved.